Signature Resources Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.6K Sell
67
-5
-7% -$2.4K 0.01% 191
2026
Q1
$35.4K Buy
72
+34
+89% +$18.5K 0.02% 166
2025
Q4
$22K Buy
38
+2
+6% +$1.13K 0.01% 207
2025
Q3
$17.5K Hold
36
0.01% 221
2025
Q2
$14.6K Hold
36
0.01% 238
2025
Q1
$17.9K Hold
36
0.02% 164
2024
Q4
$18.7K Sell
36
-10
-22% -$5.5K 0.02% 152
2024
Q3
$28.5K Hold
46
0.03% 123
2024
Q2
$25.4K Buy
46
+35
+318% +$20.1K 0.02% 131
2024
Q1
$5.84K Hold
11
0.01% 229
2023
Q4
$5.84K Buy
+11
New +$5.32K 0.01% 231

Other funds holding TMO

Signature Resources Capital Management's TMO Position: Q2 2026 in Review

Signature Resources Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 6.9% in Q2 2026, selling an estimated $2.4K and leaving 67 shares worth $33.6K. The position accounts for 0.01% of the portfolio, ranked #191.

Signature Resources Capital Management first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $35.4K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Signature Resources Capital Management held 67 shares of Thermo Fisher Scientific worth $33.6K as of Q2 2026.
  • Signature Resources Capital Management sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #191 holding.
  • Signature Resources Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Signature Resources Capital Management's Thermo Fisher Scientific position peaked at $35.4K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.